Executive summary Despite the improvements in outcomes for cardiovascular disease
(CVD) over the last 20 years, it remains the major cause of morbidity and mortality in the …

Preamble Guidelines aim to present all the relevant evidence on a particular issue in order
to help physicians to weigh the benefits and risks of a particular diagnostic or therapeutic …

Atherosclerotic cardiovascular disease (CVD) is a chronic disorder developing insidiously
throughout life and usually progressing to an advanced stage by the time symptoms occur. It …

Cardiovascular diseases remain the first killer in the Western countries. Equivalent
contributions of prevention initiatives, pharmaceutical developments and technological …

These pocket guidelines provide evidence-based guidance on how to reduce the incidence
of first and recurrent clinical events due to coronary heart disease (CHD), cerebrovascular …

†European guidelines on cardiovascular disease prevention in clinical practice: executive
summary | European Heart Journal | Oxford Academic Skip to Main Content Advertisement …

European guidelines on cardiovascular prevention in clinical practice were first published in
1994 and have been regularly updated, most recently in 2016, by the Sixth European Joint …

Executive summary European guidelines on cardiovascular disease prevention in clinical
practice Third Joint Task Force of European and other Societies on Cardiovascular Disease …

Objective To identify, critically appraise and summarise existing systematic reviews on the
impact of global cardiovascular risk assessment in the primary prevention of cardiovascular …

Prevention of coronary heart disease in clinical practice: recommendations of the task force
of the European Society of cardiology, European atherosclerosis Society and European …